The absence of the pro-inflammatory subcluster of basal epithelial cells in P4HA1-deficient 6Ho mice suggests that P4HA1 plays a key role in regulating pro-inflammatory responses in these cells and may serve as a potential therapeutic target for triple-negative breast cancer treatment. The gene discussed is P4HA1; the disease is triple-negative breast carcinoma.